These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23927031)

  • 1. Yellow fever revaccination guidelines change - a decision too feverish?
    Grobusch MP; Goorhuis A; Wieten RW; Verberk JD; Jonker EF; van Genderen PJ; Visser LG
    Clin Microbiol Infect; 2013 Oct; 19(10):885-6. PubMed ID: 23927031
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever vaccine: WHO position on the use of fractional doses – June 2017.
    Wkly Epidemiol Rec; 2017 Jun; 92(25):345-50. PubMed ID: 28643507
    [No Abstract]   [Full Text] [Related]  

  • 3. The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice.
    Wilder-Smith A; Hill DR; Freedman DO
    Am J Trop Med Hyg; 2008 Mar; 78(3):359-60. PubMed ID: 18337324
    [No Abstract]   [Full Text] [Related]  

  • 4. Fractional-Dose Yellow Fever Vaccination - Advancing the Evidence Base.
    Vannice K; Wilder-Smith A; Hombach J
    N Engl J Med; 2018 Aug; 379(7):603-605. PubMed ID: 29995585
    [No Abstract]   [Full Text] [Related]  

  • 5. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    Staples JE; Bocchini JA; Rubin L; Fischer M;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):647-50. PubMed ID: 26086636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial with unlicensed yellow fever vaccine in Japan.
    Ujiie M; Terada M; Kobayakawa M; Ohmagari N
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 30657930
    [No Abstract]   [Full Text] [Related]  

  • 7. Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand.
    Barrett AD
    N Engl J Med; 2016 Jul; 375(4):301-3. PubMed ID: 27276108
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations.
    Who
    Vaccine; 2015 Jan; 33(1):76-7. PubMed ID: 24852721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever vaccination - Once in a lifetime?
    Grobusch MP; van Aalst M; Goorhuis A
    Travel Med Infect Dis; 2017; 15():1-2. PubMed ID: 28013052
    [No Abstract]   [Full Text] [Related]  

  • 10. Yellow fever vaccination: is one dose always enough?
    Patel D; Simons H
    Travel Med Infect Dis; 2013; 11(5):266-73. PubMed ID: 24074827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of the Arilvax; yellow fever vaccine.
    Barrett AD
    Expert Rev Vaccines; 2004 Aug; 3(4):413-20. PubMed ID: 15270646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yellow Fever Vaccine for People Living With HIV Infection.
    Andrews L
    J Assoc Nurses AIDS Care; 2018; 29(2):345-347. PubMed ID: 29217414
    [No Abstract]   [Full Text] [Related]  

  • 13. INFECTIOUS DISEASES. Yellow fever outbreak triggers vaccine alarm.
    Kupferschmidt K
    Science; 2016 Apr; 352(6282):128-9. PubMed ID: 27124428
    [No Abstract]   [Full Text] [Related]  

  • 14. Yellow fever revaccination during infliximab therapy.
    Scheinberg M; Guedes-Barbosa LS; Mangueira C; Rosseto EA; Mota L; Oliveira AC; Lima RA
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):896-8. PubMed ID: 20535801
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious disease. Resurgence of yellow fever in Africa prompts a counterattack.
    Roberts L
    Science; 2007 May; 316(5828):1109. PubMed ID: 17525307
    [No Abstract]   [Full Text] [Related]  

  • 16. [Yellow fever: new recommendations].
    Rochat L; Genton B
    Rev Med Suisse; 2014 May; 10(429):1014-9. PubMed ID: 24908746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yellow fever, Senegal (update).
    Wkly Epidemiol Rec; 2002 Nov; 77(45):373-4. PubMed ID: 12442552
    [No Abstract]   [Full Text] [Related]  

  • 18. Yellow fever urban outbreak in Angola and the risk of extension.
    Wkly Epidemiol Rec; 2016 Apr; 91(14):186-92. PubMed ID: 27066610
    [No Abstract]   [Full Text] [Related]  

  • 19. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
    O'Brien B; Leggat PA
    Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yellow fever vaccine as a vehicle to better travel medicine.
    Spira A
    J Travel Med; 2005; 12(6):303-5. PubMed ID: 16343380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.